Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanqi Huazhi Pills for internal hemorrhoid prolapse
ChiCTR1800019420Phase 4Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Sanqi Huazhi in internal hemorrhoid and hemorrhoid (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Hemorrhoids prolapse. Started Aug 2018; status: recruiting.
02
Drugs
Sanqi Huazhi
03
Conditions
internal hemorrhoidhemorrhoid
Beyond the preview
Go deeper on ChiCTR1800019420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019420.